Technologies rarely advance at a steady and predictable pace, but new platforms and newer ideas are already shaping the future of clinical lab testing. This article from the April 2014 issue highlights a handful of companies that are working to bring new diagnostic technologies to market and improve patient care.
Read More
CDC’s grant of more than $1.25 million to the College of American Pathologists will help laboratory professionals improve the delivery of patient testing guidelines and cancer reporting.
Read MoreA new collaboration plans to provide genomic profiling and information for patients that have been unsuccessful on repeated therapy for the group of cancers that include leukemias, lymphomas, and myeloproliferative and myelodysplastic diseases.
Read MoreVisualDx, a web-based clinical decision support system and mobile app from Logical Images, Rochester, NY, has been honored in the Best in KLAS report for the third year in a row.
Read More
Companion diagnostics provide information about a patient’s genetic and genomic characteristics to guide decisions about treatment with specific drugs. In this article from the March issue of CLP, contributing writer Gary Tufel examines how this relatively recent phenomenon is spawning a significant increase in pharmaceutical companies partnering with diagnostics firms to develop and produce such diagnostics—and thus more targeted and effective treatments.
Read More